比特派官网app下载苹果|uicc
作者： 比特派官网app下载苹果
2024-03-07 21:39:22
Leading global action on cancer | UICC
Leading global action on cancer | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Union for International Cancer Control (UICC)
About us
Spotlight on
Read more
Read more
Read more
Read more
Read more
Read more
Leading global action on cancer
Members
Partners
Countries
Supporting the cancer community
UICC provides learning and development opportunities for members. Member organisations have privileged access to UICC events and voting rights as part of the General Assembly.
UICC fosters a learning culture across the cancer community, encourages collaboration and offers a range of knowledge sharing opportunities.
Uniting cancer professionals and policy makers in premier events like the World Cancer Congress and World Cancer Leaders’ Summit is an essential part of UICC’s work. UICC also leads on the global World Cancer Day campaign.
Driving global impact
Political will and a national strategy that prioritises targeted investments in cancer control as well as action at the international level can reduce the global cancer burden.
UICC has created several new organisations and initiatives to address long-term public health challenges and unmet needs.
While UICC works on all aspects of cancer control covering all cancer types, the organisation pays special attention to a number of key thematic areas.
Explore more
What is cancer control?
Cancer control aims to reduce the incidence, morbidity and mortality of cancer and to improve the quality of life of cancer patients in a defined population, through the systematic implementation of evidence-based interventions for prevention, early detection, diagnosis, treatment, and palliative care.
Explore more
News and updates
Global initiatives and renewed financing to bridge gaps in detecting and treating women’s cancers
Read more
The ATOM Coalition partners with IDA Foundation to improve access to oncology medicines in LLMICs
Read more
Lancet study reveals over a billion people face obesity, a known cancer risk factor
Read more
View all news and updates
Featured resources
Author(s):
Union for International Cancer Control (UICC)
Download (
9.13 MB
)
Author(s):
Union for International Cancer Control (UICC)
Download (
2.95 MB
)
Author(s):
Union for International Cancer Control (UICC)
Download (
8.35 MB
)
View all resources
Upcoming events
Stay up to date with all the information related to our contributions and to the international events in the field.
See all upcoming events
Suggest an event
17 September2024
-
19 September2024
Geneva
,
Switzerland
Organiser(s):
Union for International Cancer Control (UICC)
See details
Our
partners
Over 60 partners drive long-term and measurable changes in cancer control for the benefit of the global cancer community.
View all partners
Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases.
Cancer Research UK is the world’s largest independent funder of cancer research. Its vision is to bring forward the day when all cancers are cured. Since 1902 CRUK has found new ways to prevent, diagnose and treat cancer. CRUK-funded scientists’ pioneered early radiotherapy, developed some of the world’s top cancer drugs and discovered the tumour suppressor gene, p53. Its work has saved millions of lives across the world. CRUK invests $500m annually in world-leading research across all 200 different types of cancer, working with partners in Europe, North America and Asia to accelerate research progress. It provides information to those affected by cancer, works to increase cancer awareness, and uses its powerful, independent voice to keep cancer at the top of the political agenda. CRUK funds some of the world’s leading experts in tobacco research and is a key player in international tobacco control. It became a full UICC member in 1986.
Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research.
Danish Cancer Society aims to prevent the development of cancer, to improve patients' chances of successful recovery, to limit the physical, psychological and social side-effects of cancer.
The group`s main activities are within research, patient support and prevention. The society has recently begun to focus on wellness programs like: health, food, and biotech advances.
The Dutch Cancer Society is a nation-wide organization for cancer control in the Netherlands. The society was funded in 1949 by Queen Wilhelmina. Her granddaughter, Her Royal Highness Princess Beatrix, is the current patron. The Dutch Cancer Society’s ideal world is one in which nobody dies from cancer ever again. We want fewer people to get cancer, more people to cure, and patients to have a better quality of life, during and after the disease. That’s why we fund and facilitate scientific research, influence policy, and share our knowledge about cancer and its treatment. To make this possible, we raise funds and establish links with other parties involved in cancer control, both here in the Netherlands and elsewhere. The Dutch Cancer Society is entirely dependent on community involvement and donations. Over 100.000 volunteers support the Dutch Cancer Society whether it comes to local or nation-wide fundraising, scientific or policy advice in several councils and committees. We can rely on nearly 1.500 local committees that organize fundraising activities e.g. our annual door-to-door campaign to raise funds for the fight against cancer. The Dutch Cancer Society is supported by over 1 million donors. The Dutch Cancer Society’s office is located in Amsterdam; our professional staff amounts to 198 staff members.
N°1 dermatologist recommended skincare brand worldwide, La Roche-Posay’s mission is to offer life-changing dermatological skincare solutions. Recommended by 90,000 dermatologists worldwide*, La Roche-Posay was created by a pharmacist in 1975. The brand is today present in over 60 countries. It offers a unique range of daily skincare developed for every skin type to complement their dermatological treatments and promote good skincare practices adapted to each skin concern. The brand develops formulas with its exclusive Selenium-rich water, also used at its Thermal Center, the first Dermatology Center in Europe, due to its antioxidant and soothing properties. The products are developed using a strict formulation charter with a minimal number of ingredients and are formulated at optimal concentrations. Additionally, La Roche-Posay products undergo stringent clinical testing for efficacy and safety, even on sensitive skin. The La Roche-Posay Cancer Support program includes two pillars related to the fight against cancer: Fight With Care to improve patients’ quality of life during all cancer treatment for better adherence and higher chances of healing, and Save Your Skin to prevent skin cancer specifically. On both topics, the brand is committed to raising awareness, training health care professional and the general public, and helping patients by supporting NGOs’ projects beyond skincare. Since 2019, the Fondation La Roche-Posay is also committed to improving the life of children with cancer and their families. In 2020, the brand went a step further in its commitment to protect the planet. Besides launching the first eco-designed tubes integrating cardboard, the brand announced a long-term plan to reduce its use of virgin plastic by 70% in 2025.
For additional information about La Roche-Posay, visit www.laroche-posay.com.
*source: survey on the dermocosmetic market carried out by iqvia and other partners (ipsos, tns) between september 2017 and august 2018 among dermatologists in 62 countries.
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases. MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
The National Cancer Institute (NCI) is the federal government's principal agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and the families of cancer patients.
Novartis Oncology is a global leader in transforming outcomes for people with cancer. We offer a wide range of innovative therapies to help meet patient needs and have one of the strongest, most productive pipelines in the industry. Our research is driven by a distinctive scientific and clinical strategy focused on precision oncology – understanding how cancer develops on a genomic level and developing drugs that hone in on those targets.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development and manufacture of healthcare products. Our global portfolio includes medicines and vaccines, as well as many of the world’s best-known consumer healthcare products. We work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. We collaborate with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world.
Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines.
The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide.
Sanofi is a global life sciences company committed to improving access to healthcare and supporting the people we serve throughout the continuum of care. From prevention to treatment, Sanofi transforms scientific innovation into healthcare solutions, in human vaccines, rare diseases, multiple sclerosis, oncology, immunology, infectious diseases, diabetes and cardiovascular solutions and consumer healthcare. More than 110,000 people at Sanofi are dedicated to make a difference on patients’ daily life, wherever they live and enable them to enjoy a healthier life.
Get involved
194 days
until
World Cancer Congress 2024
Learn more
334 days
until
World Cancer Day 2025
Learn more
Are you interested in joining a dynamic network of over 1,150 members?
Become a member
Would you like to support the work of UICC and the cancer community?
Become a partner
Are you organising a cancer-related event and would like to feature it in our events section?
Submit an event
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration
About UICC | UICC
About UICC | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Breadcrumb
Who we are | About UICC
About UICC
UICC's mission is to unite and support the cancer community to reduce the global cancer burden, to promote greater equity, and to ensure that cancer control continues to be a priority in the world health and development agenda.
The Union for International Cancer Control (UICC) is the oldest and largest global membership organisation dedicated to taking action on cancer.
UICC's mission is both to unite and support the cancer community in its efforts to reduce the global cancer burden, promote greater equity and ensure that cancer control remains a priority on the global health and development agenda.
Founded in 1933 and based in Geneva, Switzerland, UICC has over 1150 member organisations in 172 countries and territories. The membership base includes the world’s major cancer leagues and societies, research institutes, treatment centres, hospitals, ministries of health, public health agencies and patient support groups.
UICC has consultative status with the United Nations Economic and Social Council (ECOSOC) and has official relations with the World Health Organization (WHO) and partnerships with the International Agency for Research on Cancer (IARC), the International Atomic Energy Agency (IAEA) and the United Nations Office on Drugs and Crime (UNODC). UICC is committed to working in partnership, and engages over 60 partners, including associations, companies and foundations, to amplify and extend its collective impact.
UICC is a founding member of the NCD Alliance, the McCabe Centre for Law & Cancer, the International Cancer Control Partnership (ICCP) and established the City Cancer Challenge Foundation in 2019 and the Access to Oncology Medicines (ATOM) Coalition in 2022.
UICC's membership (visit the Map of members for more information)
Partnering for success
UICC has consultative status with the United Nations Economic and Social Council (ECOSOC) and has official relations with the World Health Organization (WHO) and partnerships with the International Agency for Research on Cancer (IARC), the International Atomic Energy Agency (IAEA) and the United Nations Office on Drugs and Crime (UNODC). UICC is committed to working in partnership, and engages over 60 partners, including associations, companies and foundations, to amplify and extend its collective impact.
What makes UICC unique
UICC is the only global cancer organisation representing all cancer types, across the continuum of cancer care (prevention, early detection, treatment and care, palliative care). The organisation connects the most influential health leaders, governments, civil society, policy makers and private sector through its platforms and activities.
Uniting the cancer community and creating new initiatives
UICC has reached millions of people with World Cancer Day, welcomed thousands of delegates at its World Cancer Congresses and convened top decision-makers in the health and cancer communities at its World Cancer Leaders' Summits.
Since 2009, it has launched five new organisations and initiatives: the NCD Alliance (2009), the McCabe Centre for Law & Cancer (2012), the International Cancer Control Partnership (2013), the City Cancer Challenge Foundation or C/Can (2017) and the ATOM (Access to Oncology Medicines) Coalition (2022).
Governance
UICC is governed by its member organisations. They meet in a General Assembly, which is held every two years around the World Cancer Congress. A Board of 17 Directors, elected by full members at the General Assembly, acts as the executive body of UICC.
Science and evidence at UICC's core
The TNM Classification of Malignant Tumours, the global standard for cancer staging, is regularly reviewed and updated by the UICC TNM Project, alongside its companion publications, the TNM Supplement and the TNM Atlas. The UICC TNM Project, together with the International Agency for Research in Cancer and the National Cancer Institute, has developed a new classification system, “Essential TNM”, which can be used notably in low-income settings to collect stage data when complete information is not available.
The International Journal of Cancer is UICC’s official journal since 1966 and a world renowned publication in experimental, clinical and epidemiological research.
The Manual of Clinical Oncology, published by UICC, is a concise reference that covers state-of-the-art multidisciplinary clinical oncology to meet the needs of clinicians caring for cancer patients throughout the world.
UICC partners with the American Society of Clinical Oncology on the open-access, online-only JCO Global Oncology publication.
UICC's growth over the years
Resources about UICC
Author(s):
Union for International Cancer Control (UICC)
Download (
2.95 MB
)
Author(s):
Union for International Cancer Control (UICC)
Download (
9.13 MB
)
Author(s):
Union for International Cancer Control (UICC)
Download (
922.21 KB
)
Author(s):
Union for International Cancer Control (UICC)
Download (
397.66 KB
)
Author(s):
Union for International Cancer Control (UICC)
Download (
330.34 KB
)
Author(s):
UICC
Download (
330.21 KB
)
Explore more
Cancer control aims to reduce the incidence, morbidity and mortality of cancer and to improve the quality of life of cancer patients in a defined population, through the systematic implementation of evidence-based interventions for prevention, early detection, diagnosis, treatment, and palliative care.
Read more
Find out more about UICC's activities by reading our annual reports.
Read more
The UICC Team is composed of over 40 passionate individuals eager to make a difference in the fight against cancer.
Read more
UICC has received or been shortlisted for a number of awards recognising its efforts in improving its various services to its members, partners and the general cancer community.
Read more
UICC plays a unique and important role in the global cancer and health communities.
Read more
At UICC, issues of equity and gender equality in global health are embedded in the core functioning and vision of the organisation.
Read more
TNM (“Tumor”, “Nodes”, “Metastases”) cancer staging system is a globally recognised standard and unified system for classifying the extent of spread of cancer.
Read more
Tags
About UICC
Mission
Membership
Members
Partners
Networks
Governance
World Cancer Declaration
Convening
Capacity Building
Advocacy
Roadmap
Last update
Friday 16 February 2024
Share this page
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration
GLOBOCAN 2020: New Global Cancer Data | UICC
GLOBOCAN 2020: New Global Cancer Data | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
News
17 December 2020
GLOBOCAN 2020: New Global Cancer Data
UPDATE: IARC has released the updated Globocan 2022 Global cancer data. Visit the new article here.
Header Paragraph
The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetime, and 1 in 8 men and 1 in 11 women die from the disease. These new estimates suggest that more than 50 million people are living within five years of a past cancer diagnosis. Ageing populations globally and socio-economic risk factors remain among the primary factors driving this increase.
Breast cancer represents 1 in 4 cancers diagnosed among women globally. Colorectal, lung, cervical, and thyroid cancers are also common among women.
GLOBOCAN 2022 is now available
IARC released on 01 February 2024 new estimates on the global cancer burden, indicating 20 million new cancer cases and 9.7 million deaths globally, with lung and breast cancer being most common.
See the Globocan 2022 data
Lung cancer and prostate cancer are the most common among men, together accounting for nearly one-third of all male cancers.
Inequity in health care between higher and lower resourced settings
For the 1st time, female breast cancer has become the most commonly diagnosed cancer, surpassing lung cancer, in particular due to high prevalence in low- and middle-income countries (LMICs). Lung cancer remains the leading cause of cancer deaths, not only in many LMICs but also in most higher-income regions like North America, Europe and Australia.
There continue to be significant disparities between higher and lower-income countries, with GLOBOCAN 2020 predicting that countries classified with "Low or Medium Human Development Index (HDI) "will have the greatest relative increases in #cancer incidence by 2040.
The need for more reliable national cancer data
IARC draws attention to a situation of limited data in certain countries and emphasises the need for better cancer data registries:
"Caution must be exercised when interpreting these estimates, given the limited quality and coverage of cancer data worldwide at present, particularly in low- and middle-income countries. IARC’s approach is not only to evaluate, compile, and use the data from the Agency’s collaborators in these estimates but also to work alongside national staff to improve local data quality, registry coverage, and analytical capacity. The clear need for investment in population-based cancer registration in low- and middle-income countries led to the launch of the Global Initiative for Cancer Registry Development (GICR), coordinated by IARC. The goal of the GICR is to inform cancer control through defined improvements in the coverage, quality, and use of population-based cancer registration data worldwide."
For instance, the International Journal of Cancer reports in an article, "Progress, challenges and ways forward supporting cancer surveillance in Latin America", that less than 3% and 10% of the respective populations of Central America and South America are covered by high‐quality cancer registries.
Effective National Cancer Control Plans, a primary tool in the fight against cancer, rely on solid data registries. For more information on the IARC Regional Hubs for Cancer Registration, please visit the GICR webpage.
Tags
GLOBOCAN 2020
GLOBOCAN
International Agency for Research on Cancer
IARC
Cancer incidence
CEO Articles
Last update
Wednesday 06 March 2024
Share this page
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration
Fellowships | UICC
Fellowships | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Breadcrumb
What we do | Member benefits
Learning and development
Fellowships
Fellowships
Established in 1962, the Fellowships is one of UICC's oldest and most established portfolio of programmes.
Go to section
About
Types of UICC Fellowships
Impact
Programme Overview
What do the Fellows say ?
Chairs & Committee members
Partners
Established in 1962, the Fellowships programme is one of UICC's oldest and most established initiative. Whilst it has developed and adapted over time, the programme's objective remains the same: to strengthen workforce capacity in cancer control by facilitating the exchange of knowledge, expertise and technical skills in cancer prevention, early detection and diagnosis, treatment and palliative care. UICC Fellowships also enable networking and collaboration across institutions and countries.
What are UICC Fellowships?
Short-term international training and learning opportunities for professionals working in all aspects of cancer control (click here and here for examples of recently awarded Fellows and their chosen topics).
Individual in-person visits or virtual sessions with leading experts to gain technical knowledge and tailored advice.
Types of UICC Fellowships
Enabling the exchange of knowledge, skills and techniques for cancer control through two weeks to two month international visits.
Read more
Destinées aux personnels de santé travaillant dans le domaine du cancer basés en Afrique francophone, une visite d’un mois pour acquérir de nouvelles compétences et renforcer des collaborations.
En savoir plus
Supporting individuals from UICC member organisations to obtain expert learning and guidance in cancer control via a series of facilitated one-to-one video calls.
Read more
Training of postdoctoral and clinical cancer researchers through three-month international collaborative projects.
Read more
Long-term impact of Fellowships
The UICC Fellowships programme support individuals from all over the world, and from all areas of cancer control. Over 4,000 fellowships have been awarded to date.
Learn more about the long-term impacts of the Fellowships programme
Programme overview
Fellowship programmes
Call dates
Duration of visit
Award amount
Eligible Candidates
Language of Application
Technical Fellowships
2024 dates to be confirmed
From two weeks to two months
2,200 to 5,800 USD
Master's Degree or medical equivalent
English
Bourses pour l’Afrique
Dates pour 2024 à confirmer
De deux semaines jusqu'à deux mois
2,200 à 5,800 USD
Titulaires d’un Master ou équivalent
Français
YY study grants
Open Autumn 2024, close date to be confirmed
Three months
up to maximum 10,000 USD
>2 years post PhD
English
Virtual Fellowships
1 January- 31 December 2024
Four one-hour video calls
-
Cancer control professionals working in a UICC member organisation
English, French or Spanish
What do the Fellows say ?
"The more that you read, the more things you will know. The more that you learn, the more places you’ll go. It was really a success story for my professional growth and academic excellence as it helped in shaping my technical skills and in learning new ideas ensuring professional development to keep pace with the modern era of precise patient service delivery ensuring early detection of cancer increasing survival rate."
Amir Ali | 2023 Technical Fellowship
"I believe that without this grant I would not have been able to understand the practical application of treatment using pulsed low-dose rate radiotherapy, which in turn can treat recurrent tumors patients with positive results. Now, with the gained experience from this fellowship, many more projects can be initiated that would be helpful in the future development process of our cancer centers."
Mahmoud Hassan Abdelgawad | 2023 YY Study Grants
Programme chairs and reviewer committee members
Each of the Fellowships programmes is supported by a pool of external reviewers, international experts across all fields of cancer control. Each application is reviewed by a minimum of two reviewers, and a final decision is made by the respective Programme Chair.
UICC would like to acknowledge and thank the Programme Chairs and reviewers for their time and dedication.
2023 Programme chairs and review committees (PDF)
In August 2023, UICC expressed its sincere thanks to Profs. Nicol Keith and Rob Jones with awards to acknowledge well over a decade of dedicated service as the Programme Chairs of the UICC Technical Fellowships programme.
Fellowship partners
In 2023, in addition to the partners below, Fellowships were supported through the Unitaid-funded SUCCESS project, UICC’s Breast Cancer programme and World Cancer Day
Founded in 1951 to support cancer research, the Swedish Cancer Society is an independent non-profit organization with the vision of finding cures for cancer. The overall aim of the Society is to achieve a higher survival rate and a reduction in the incidence of cancer. Their main task is to raise and distribute money for cancer research. As one of the largest financiers of cancer research in Sweden, the Swedish Cancer Society essentially acts as a national research council. Thanks to the organization’s extensive knowledge about cancer, the Swedish Cancer Society is also active in areas such as public opinion and spreading knowledge about cancer, as well as results of cancer research.
Founded in 1936, the Cancer Society of Finland is the largest patient and public health organisation in Finland as well as being an expert organisation nationally. The aim of CSF is to prevent cancer, promote health and ensure a good quality of life for people with cancer. The CSF comprises of 12 regional cancer societies and six national patient organisations. The CSF’s member societies are independent actors that adhere to commonly agreed values and working principles. Activities are based on the results of scientific research, which is funded through grants offered by the Cancer Foundation Finland sr and the Foundation for the Finnish Cancer Institute sr. The Finnish Cancer Registry is a statistical and epidemiological cancer research institute that has run a database of all cases of cancer in Finland since 1952.
The Japan National Committee for UICC is a group of Japanese organisations that are members of the Union for International Cancer Control (UICC), gathered to support the UICC to strive to realise the World Cancer Declaration. Currently UICC-Japan is composed of 29 full Japanese UICC members, including major cancer specialists in Japan, cancer centres, research institutes, research funds, hospitals and cancer associations.
National Cancer Centre (NCC) was established in 2000. It strives to improve national health and welfare by reducing the incidence and mortality of cancer through research, patient care, education & training, and support for the national cancer control programs. "Vision 2020" is a program that represents the organizations goals into the future, where it fights to protect the Korean people from cancer through innovative research, quality medical care, optimal training of cancer experts, and support for national cancer control programs.
The mission of the Prevent Cancer Foundation® is saving lives across all populations through cancer prevention and early detection. The Prevent Cancer Foundation® is one of the leading voluntary health organizations in the U.S. and the only U.S. non-profit focused solely on cancer prevention and early detection. Founded in 1985, it has catapulted cancer prevention to prominence and fulfils its mission through research, education, outreach and advocacy. The Foundation’s vision is to Stop Cancer Before It Starts!®
Princess Margaret Hospital (PMH), a teaching hospital of the University of Toronto, has achieved an international reputation as a global leader in the fight against cancer and is considered one of the top comprehensive cancer treatment and research centres in the world. PMH and its research arm, the Ontario Cancer Institute work with a clinical and research staff at which represents many of the world's leading experts in oncology. It prides itself on building caring relationships with its patients. With each patient case, they combine state-of-the art diagnosis and treatment with compassion and care. PMH was accepted as a full UICC member in 1992.
For more than a century, MSD, a leading global biopharmaceutical company, has been inventing for life, bring forward medicines and vaccines for the world’s most challenging diseases. MSD is a trade name of Merck & Co., Inc., Kenilworth, N.J., USA. Through their prescription medicines, vaccines, biologic therapies, and animal health products, they work with customers and operate in more than 140 countries to deliver innovative health solutions. MSD also demonstrates their commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to advance the prevention and treatment of diseases that threaten people and communities around the world - including cancer, cardio-metabolic diseases, emerging animal diseases, Alzheimer’s disease and infectious diseases including HIV and Ebola.
Explore more
Virtual Fellowships allow cancer professionals from UICC member organisations to obtain expert learning and guidance in cancer control in English, French or Spanish, through a series of four one-to-one video calls with experts.
Read more
Transfer of cancer control knowledge, skills and techniques through one month international visits
Read more
En 2017 UICC a lancé un programme de bourses pour le personnel de santé et les autres professionnels travaillant dans le domaine du cancer en Afrique francophone.
Read more
The YY Study Grants provide an important opportunity to advance cancer research through international collaboration.
Read more
In the last 50 years UICC has awarded over 4000 fellowships to cancer professionals from over 140 different countries.
Read more
Fellows who have successfully completed a fellowship are invited to join the Association of UICC Fellows.
Read more
UICC regularly reviews its capacity building programmes to ensure UICC programmes are not only contemporary but also targeted to meet the emerging needs of cancer control organisations and contribute to the development of cancer control at a country level.
Read more
Related pages
Fostering an influential cancer community with the skills, knowledge, networks and resources to achieve effective cancer prevention and control.
UICC has been supporting the continuing education of cancer control professionals through online learning since 2014.
UICC has a long history of building capacity for cancer organisations globally through grant making.
The UICC's organisational leadership workstream is designed to provide leaders in cancer organisations at all levels with spaces to acquire new skills, and opportunities to collaborate and take action together.
UICC’s Cancer Advocates programme provides an opportunity for civil society organisations (CSOs) from low- and middle-income countries to gain the skills and knowledge to engage in national advocacy efforts for improved cancer control. The programme is available in English, French and Spanish.
UICC's Virtual Dialogues provide members, and the cancer community, with regular opportunities to connect, exchange knowledge, access expert insights, and share solutions from the comfort of one's office or home.
Launched in 2018, the Patient Group Mentoring programme is a tailored mentorship programme dedicated to building capacity of a representative cohort of patient groups at the regional level.
Tags
Fellowships
Testimonials
impact
grants
knowledge
Networks
Last update
Wednesday 28 February 2024
Share this page
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration
World Cancer Congress 2024 | UICC
World Cancer Congress 2024 | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Breadcrumb
What we do | Events
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2024
UICC’s World Cancer Congress 2024 will take place on 17-19 September 2024 in Geneva, Switzerland.
Considering the success and positive feedback received for World Cancer Congress 2022, the UICC Board has decided that the next edition in 2024 will also be held at the International Conference Centre of Geneva, Switzerland, from 17 to 19 September 2024, near the UICC office. This will allow participants to benefit once again from the proximity of WHO and other major health organisations with whom UICC entertains close relations.
Once again, the UICC World Cancer Congress played its core role of convening and uniting the cancer and NCD communities, and drive progress in reducing the global burden of cancer through the power of knowledge sharing and collective action.
Visit worldcancercongress.org for more information
Latest news about the World Cancer Congress
World Cancer Congress 2024 preliminary programme and early registration
Read more
Take an active role in shaping the programme of UICC’s World Cancer Congress 2024!
Read more
Update on World Cancer Congress 2024
Read more
View more
Related pages
The World Cancer Congress (WCC) is a recognised international conference that encourages effective knowledge transfer and best practices exchange amongst global cancer control and health experts.
UICC’s World Cancer Congress 2022 took place on 18-20 October in Geneva
Find our more about the past World Cancer Congresses
Tags
World Cancer Congress
World Cancer Congress 2024
Last update
Friday 23 June 2023
Share this page
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration
TNM Classification of Malignant Tumours | UICC
TNM Classification of Malignant Tumours | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Breadcrumb
What we do | Sharing knowledge
TNM Classification of Malignant Tumours
TNM Classification of Malignant Tumours
Published by the Union for International Cancer Control, the TNM Classification of Malignant Tumours is a globally recognised standard for classifying the extent of spread of cancer.
Go to section
What is the TNM cancer staging system?
What does TNM stand for?
Why adopt the TNM Classification?
More about TNM
Further reading
The classification of cancer by anatomic disease extent, i.e. stage, is the major determinant of appropriate treatment and prognosis. Stage is an increasingly important component of cancer surveillance and cancer control and an endpoint for the evaluation of the population-based screening and early detection efforts.
UICC has maintained and published the UICC TNM Classification of Malignant Tumours for over 70 years. The UICC TNM classification is the internationally accepted standard for cancer staging.
The TNM classification is an anatomically based system that records the primary and regional nodal extent of the tumour and the absence or presence of metastases.
UICC Podcast on TNM
What does TNM stand for?
Each individual aspect of TNM is termed as a category:
T category describes the primary tumour site and size
N category describes the regional lymph node involvement
M category describes the presence or otherwise of distant metastatic spread
The TNM Classification of Malignant Tumours, 8th Edition, published in 2016 provides the latest, internationally agreed-upon standards to describe and categorize cancer stages and progression.
Order your copy now
(UICC members have a discount on UICC's publications published by Wiley).
Why adopt the TNM cancer staging system?
The UICC TNM staging system is the common language in which oncology health professionals can communicate on the cancer extent for individual patients as a basis for decision making on treatment management and individual prognosis but can also be used, to inform and evaluate treatment guidelines, national cancer planning and research.
More specifically, the objectives of the TNM classification are the following:
Aid treatment planning,
Provide an indication of prognosis,
Assist in the evaluation of treatment results,
Facilitate the exchange of information between treatment centres,
Contribute to continuing investigations of human malignancies,
Support cancer control activities, including through cancer registries.
The TNM classification is a unified standard and is a prerequisite for ensuring the quality of care in all resource-settings. It goes beyond clinician practice and constitutes vital information for policy-makers developing or implementing cancer control and prevention plans and it is therefore important to include the TNM classification as part of cancer registration.
Any questions?
Please download the FAQ's page for answers to your questions on cancer staging. If you do not find the answer to your question, you can contact the TNM helpdesk:
Contact the helpdesk
Explore more
Find out more how the TNM classification is defined and updated
Read more
Editions of the TNM Classification of Malignant Tumours
Read more
eCancer and UICC jointly produced a set of 7 modules on TNM staging
Read more
Do you have questions on cancer staging?
Read more
Information on anatomical extent of disease at presentation or stage is central to cancer surveillance
Read more
You can also read the documents
Read or download
Read or download
Read or download
Related pages
UICC fosters a learning culture across the cancer community, encourages collaboration and provides a range of knowledge sharing opportunities.
UICC's Virtual Dialogues provide members, and the cancer community, with regular opportunities to connect, exchange knowledge, access expert insights, and share solutions from the comfort of one's office or home.
Established in 1962, the Fellowships is one of UICC's oldest and most established portfolio of programmes.
Learn more about the International Journal of Cancer and the JCO Global Oncology (JCO GO).
The Global Initiative for Cancer Registry Development (GICR) is a multi-partner response to the disparity in robust cancer statistics across the globe, led by the International Agency for Research on Cancer (IARC) and Union for International Cancer Control (UICC).
Tags
TNM
TNM cancer staging
TNM classification
UICC
Classification
Malignant Tumours
Global Advisory Group
Last update
Friday 01 September 2023
Share this page
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration
Global initiatives and renewed financing to bridge gaps in detecting and treating women’s cancers | UICC
Global initiatives and renewed financing to bridge gaps in detecting and treating women’s cancers | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
News
07 March 2024
Global initiatives and renewed financing to bridge gaps in detecting and treating women’s cancers
Marking International Women's Day on 8 March, UICC engages with members and partners, to support international commitments on cervical and breast cancer.
Header Paragraph
Opening ceremony of the International Forum on Global Cervical Cancer Elimination Initiative in Colombia.
The most recent estimates of cancer incidence and mortality continue to highlight the stark disparities that exist in developing and surviving cancer across different levels of human development, especially when it comes to women’s cancers.
Indeed, cervical cancer accounts for less than 1% of new cancer cases and cancer-related mortality in high-income countries, but is the second most diagnosed cancer and the second highest cancer-related mortality rate after breast cancer in low- and lower middle-income countries. Survival rates for breast cancer can be as high as 99% in high-income countries, while in low-resource settings such as sub-Saharan Africa, they can be lower than 40%.
Recognising the importance of addressing women’s cancers and the unique challenges faced by women in different regions, UICC is involved in various initiatives aimed at prioritising women’s health in the context of cancer.
Marking International Women’s Day on 8 March
Marking International Women’s Day on 8 March, UICC is very pleased to announce a new partnership with Tradition Genève. The initiative aims to enable investors to contribute to enhance access to early breast cancer detection services for women, particularly in low and middle-income countries.
This week from 4-7 March, UICC joined the inaugural Forum on Cervical Cancer Elimination: Advancing the Call to Action, held from 5 to 7 March 2024, in Cartagena de Indias, Colombia, which sought to mobilise governments, donors and civil society behind cervical cancer elimination efforts. The event was co-hosted by the governments of Colombia and Spain alongside the Bill & Melinda Gates Foundation, the World Health Organization, the Pan American Health Organization, Gavi, the Vaccine Alliance, Unitaid, UNICEF, the World Bank, the Global Financing Facility and the United States Agency for International Development.
Major country, policy and programme commitments were announced already at the inaugural session of the Forum, with nearly USD 600 million in new funding over the next three years. This includes USD 180 million from the Bill & Melinda Gates Foundation, USD 400 million from the World Bank and USD 10 million from UNICEF.
Sabrina Zucchello, Senior Manager, Capacity Building at UICC, who is attending the Forum, says that “with governments and partners recommitting urgently to the global agenda, it is possible to reverse the tide and prevent annual deaths from rising to 410,000 by 2030, as currently estimated. This renewed funding sends a strong signal as well as a call to action to ensure that it happens.”
Also this week, AVAC (AIDS Vaccine Advocacy Coalition) and TogetHER for Health re-issued a joint call to action for International HPV Awareness Day on 4 March. Initially launched on World AIDS Day 2023, the call to action, which UICC has joined, urges global leaders to improve access to the HPV vaccine for people living with HIV given the significant increased risk they face in developing cervical cancer.
Indeed, UICC has been party to global efforts to address cervical cancer elimination since collaborating with WHO on drafting the Global strategy to accelerate the elimination of cervical cancer as a public health problem, adopted in November 2020.
UICC has since been working closely with its members in the implementation of the Global Strategy, by strengthening their advocacy skills and networks to enhance HPV vaccination efforts, screening programmes and access to treatment. UICC has also published several reports designed to improve the sharing of knowledge and strategies, addressing cervical cancer elimination in Africa, the critical role of CSOs in HPV vaccination, and how to finance elimination efforts.
Similarly, UICC supports its members via its Breast Cancer programme, aligned with WHO’s Global Breast Cancer Initiative (GBCI), to improve access to cost-effective screening and treatment services of breast cancer in countries where they are needed.
Since its launch four years ago, UICC’s Breast Cancer programme has, to date, engaged over 400 member organisations in capacity building activities to strengthen health care systems and improve early detection. The collective impact of most recent breast cancer programme grantees shows that over 3,000 women have been screened and over 900 professionals have been trained on screening methods in 2023 through UICC funding.
The upcoming World Cancer Congress in September in Geneva, Switzerland will be further addressing the issue of women and cancer to improve cancer care for women worldwide. Dedicated sessions will feature discussions on critical components for eliminating cervical cancer, share insights on HPV-based screening for cervical cancer, and explore collaborative efforts in Francophone Africa. These sessions will showcase the comprehensive approach needed to address women's cancers. Additionally, a workshop focused on breast cancer will be held in partnership with WHO's Global Breast Cancer Initiative, to support the dissemination of key practices and bolster the adoption of effective cancer care strategies amongst the cancer community.
Discover the preliminary programme of the World Cancer Congress 2024
Tags
women's cancers
Breast Cancer
Cervical cancer
International Women's Day
HPV
Last update
Thursday 07 March 2024
Share this page
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration
国际组织
国际组织
设为首页 | 加入收藏 | English
首 页 关于协会 协会动态 会员之声 学术交流 科普宣传 对外交流 癌症康复 期刊杂志 继教科技 科技奖励 协会党建 会员服务 联系我们
您当前的位置 ：
中国抗癌协会
>
对外交流
>
国际组织
对外交流
通知公告
外事动态
HIO英文期刊
国际组织
国际抗癌联盟 (International Union Against Cancer)
国际抗癌联盟International Union Against Cancer �CUICC（缩写为法语全称的首字母）是世界上最大的癌症预防、宣传和治疗方面的国际专业组织，与世界卫生组织（WHO）建有正式关系，是世界卫生组织有关癌症问题的最主要合作伙伴，目前国际上使用的各种预防、宣传和治疗原则、标准等均出自该联盟。联盟的宗旨是鼓励、促进癌症的预防、诊断、分类和治疗等专业方面的科研和教育，同时注重公众宣传和教育，组织各类相关活动，比如“我爱我的健康、活泼的童年”等公众教育活动。这些活动对于促进世界各国人民健康地生活、预防癌症的发生起到重要的作用。此外，联盟重视对癌症患者的关爱，组织各类患者参与的活动，使他们从心理和生理上战胜癌症。联盟设有各类鼓励青年医生从事抗癌宣传、教育、医疗、研究等的奖学金，为培养后续人才提供机会。
联盟现有来自90多个国家和地区的300多家会员组织，每两年（曾经为每四年）举办一次世界抗癌大会（World Cancer Congress）。大会是其最重要的学术交流活动。各会员组织投标争取承办世界抗癌大会。为造福我国人民和我国癌症预防、治疗和科研的发展，我会经过多年、多次投标，终于获得这个重要国际会议在中国的举办权（2010年），并成功在深圳举办。
网址： http://www.uicc.org
亚太抗癌组织联盟 (Asian and Pacific Federation of Organizations for Cancer Research and Control)
亚洲及太平洋地区肿瘤研究和控制联盟成立于1972年，致力于促进亚太地区肿瘤基础研究和临床治疗的发展和学术交流。该联盟现有来自澳大利亚、中国、日本、新西兰、菲律宾、伊朗等亚太地区国家和地区的肿瘤协会(学会)21个。郝希山院士作为唯一的一名中国人为第十九届常务理事，第二十一届亚太抗癌联盟主席。
我国成功的申办了第22届亚太肿瘤学术大会，大会将于2013年在我国天津举行。
网址： http://apfocc.org/
美国临床肿瘤学会 (American Society of Clinical Oncology )
是全球领先的肿瘤专业学术组织，宗旨是预防癌症及改善癌症服务。学会规模日益壮大，有来自100多个国家约21500多名会员，会员包括肿瘤学领域及其专科之临床肿瘤科医师、参与认可的肿瘤学训练计划的医师和医疗专家、肿瘤科护士以及肿瘤科开业医师。学会会员专攻肿瘤学领域，包括医学、血液学、放射线治疗、外科与小儿科。一年一度的ASCO年会汇聚了全球临床肿瘤学研究的精英，被公认为全球最重要的肿瘤学术会议。ASCO设有公关部门，负责向国会议员提出建议，推荐有关医疗政策及意见，对美国医疗服务有相当大的影响。其出版的期刊被国际上多家著名检索工具书和数据库收录、索引，包括：Abstracts of Health Care Management Studies, Automatic Subject Citation Index, Chemical Abstracts, Cumulative Index to Nursing and Allied Health Literature (CINAHL), Current Contents (Clinical Medicine, ISI/BioMed, Life Sciences, Science Citation Index, SCISEARCH), EMBASE/Excerpta Medica, Index Medicus/MEDLINE, Neuroscience Citation Index, and EBSCOHOST Electronic Journals Service。
网址： http://www.asco.org
美国癌症协会 (American Cancer Society)
美国癌症协会于1913年在美国成立，现总部设在乔治亚州亚特兰大市。作为一个全球性的卫生组织，它在美国各个州设立了办公室，并在全球3400个地区成立了办事处。其宗旨是通过各项活动和项目，推动全球癌症研究、教育、病患服务、科普、康复等多个层面的工作。
网址： http://www.cancer.org/docroot/home/index.asp
美国癌症研究学会 (American Association for Cancer Research)
是发布有关癌症成因、诊断、治疗和预防进展情况的权威组织。AACR通过推动癌症新知识的增长和传播而站立于防治癌症的前线。AACR是世界上成立最早、规模最大的致力于全面、创新和高水准癌症研究的科学组织。其科研范围广泛、成绩卓著，在业内享有盛名，吸引了众多的研究者。AACR的程序和服务促进了癌症科学家们知识和观念的交流，为新一代癌症研究人员提供了培训机会，也增进了公众对癌症的了解。出版了五种同行认可的科技期刊：《癌症研究》、《临床癌症研究》、《肿瘤分子治疗》、《肿瘤分子研究》和《肿瘤流行病学、生物标志和预防》。出版了CR杂志，读者群为癌症康复者、病患代言人、病人家庭、医生和科学家。该杂志提供了各种基本知识和已证实信息的共享平台，提出了关于癌症研究、病患康复和代言的各种观点。举办了专题会议和年度会议，吸引了癌症研究领域超过17000人参加。为新手以及正在培训的研究人员提供培训场所，授予会员资格和进行认可。与癌症康复者进行合作，增强公众对于癌症研究的关注，争取大额的国家资助。
网址： http://www.aacr.org.cn
版权所有：中国抗癌协会 | 技术支持：北方网 | 联系我们
津ICP备09011441号
Official website of World Cancer Day by UICC | 4 February
Official website of World Cancer Day by UICC | 4 February
Skip to main content
Join us 4 Feb
#WorldCancerDay #CloseTheCareGap
youtube
ticktok
Donate
ENFRES
AboutOur storyWhy cancer?Campaign themePress & mediaFAQsUnderstanding CancerWhat is cancer?Close the care gapKey issuesSpotlight: Cervical cancer eliminationUseful links & resourcesTake actionJoin Call to ActionShare Call to ActionWorld Cancer Day 5k ChallengeWho should get involvedShare your story4 Feb LiveMaterialsCreate your own custom posterPostersSocial mediaSocial infographicsToolkitsHow to guidesMap of ActivitiesAdd your activityOur supporters
ENFRESITARHIZH-HANSIDRU
youtube
ticktok
Donate
Watch video
Share on Twitter/X
Share on Facebook
Your browser does not support the video tag.
Create a future without cancer.
The time to act is now.
Image
Map of activities
Activities happening about the world
Search activities
Add activity
Image
About
Everything you need to know about World Cancer Day
Learn more
Image
Fundraising Guide
Your How to Guide to generate generosity
Download
Image
Stories
Read the personal stories of individuals
about the world
Learn more
Image
Social Media Guide
Your How to Guide to talk about cancer.
Download
Image
Download Materials
We've got toolkits, posters, infographics,
banners and so much more to help you
get ready for World Cancer Day.
View
Image
Advocacy Guide
Your How to Guide to use your voice
Download
Image
Event planning Guide
Your How to Guide to be an awesome host
Download
Image
Why Cancer
Cancer is a critical health and human issue
Learn more
Image
Corporate Toolkit
Get ready with the Corporate Toolkit
Download
Image
Our Supporters
Be a hero: become an official
World Cancer Day partner
Learn more
Image
Share Story
Your voice makes a big difference
Share yours
Image
Government Report
See how governments around the world took
part in World Cancer Day
Download
Image
School &
Libraries Toolkit
Get ready with the Schools and Libraries Toolkit
Download
Image
Press Page
Help provoke deeper dialogue
on a critical issue
Read more
Image
Take Action
How much time can you give ?
A hot second
1 minute
5 minutes
More!
Image
Campaign toolkit
Get ready with the Action Toolkit
Download
Image
Key issues
Explore some of the most urgent issues in cancer
Learn more
Image
Take Action
How much time can you give ?
A hot second
1 minute
5 minutes
More!
Spread the word!
FrEsEnPt-Br
Le 4 février, c’est la #JournéeMondialeContreLeCancer. Expliquez comment vous vous engagez personnellement pour réduire l’impact du cancer sur vous, sur les gens que vous aimez et sur le monde entier. #PourDesSoinsPlusJustes worldcancerday.org
Este 4 de febrero es el #DíaMundialcontraelCáncer. Comparta su compromiso personal para reducir el impacto del cáncer en usted mismo, en las personas a las que quiere y en todo el mundo. #YoSoyYVoyA worldcancerday.org
This 4 February is #WorldCancerDay. Share your personal commitment to reduce the impact of cancer for yourself, the people you love and the world. #IAmAndIWill worldcancerday.org
Cada indivíduo é importante. Qualquer ação conta. Neste #DiaMundialdoCâncer, quem é você e o que você fará? #EuSouEEuVou worldcancerday.org
TweetPostShare
Image
Brand yourself as a supporter
Update your social media pages with the
official World Cancer Day profile cover images,
for Facebook, Twitter, YouTube and LinkedIn.
Download social media covers
Image
Custom Poster tool
Get personal: customise your own
World Cancer Day poster
Create
Understanding Cancer
I want to know more about
Explore
Image
Donate today
All donations support the work of World Cancer
Day so we can reach and empower even more
people and make our impact greater
Image
Conversation starter Guide
Your How to Guide to talk about cancer
Download
Image
Govt & Cities Toolkit
Get ready with the Government and Cities Toolkit
Download
Join the Call to Action
We call on governments around the world to promote health equity, enhance cancer service accessibility, reduce disparities in cancer incidence and mortality, to finally close the care gap.
Sign the call to action
Image
Image
Why Cancer?
Cancer is a critical health and human issue.
Find out why it matters.
Read more
Take Action
How much can you give?
A hot second
1 minute
5 minutes
More!
Image
Map of Activities
Activities happening around the world
Search activities
Add activity
841 current activities
Understanding Cancer
I want to know more about
Explore
Count me in
Sign up to our newsletter
By signing up, you agree to receive World Cancer Day news, stories and updates from the Union for International Cancer Control.
Image
Download Materials
We've got toolkits, posters, infographics,
banners and so much more to help you
get ready for World Cancer Day.
View
Image
Donate today
Your donation will help improve cancer care through the Union for International Cancer Control’s actions.
UICC is the only global cancer organisation representing all cancer types, across the continuum of cancer care (prevention, early detection, treatment and palliative care).
Donate today
You can deduct your donation from your taxes in select countries.
Tax-exempt number in Switzerland: CHE-107.751.349
Tax-exempt number in the USA : 23-7208844 | Status: 501(c)(3)
Spread the word!
EnFrEs
Never underestimate the power of cooperation and collective action to save lives. Who are you and what will you do on 4 Feb? Speak up, stand up and take action together this #WorldCancerDay #CloseTheCareGap
worldcancerday.org
Ne sous-estimez jamais la capacité de la collaboration et de l'action collective à sauver des vies. Qui êtes-vous et que ferez-vous le 4 février ? Exprimez-vous, mobilisez-vous et collaborez en cette #JournéeMondialeContreLeCancer #PourDesSoinsPlusJustes
worldcancerday.org
Nunca subestime el poder de la cooperación y la acción colectiva para salvar vidas. ¿Quién es usted y qué va a hacer el 4 de febrero? Alce la voz, luche y actúe colectivamente este #DíaMundialContraElCáncer #PorUnosCuidadosMásJustos
worldcancerday.org
TweetPostShare
World Cancer Day is an inclusive platform for voices from all corners of the world, including the remotest areas.
Sutapa Biswas
Executive Director, Cancer Foundation of India
My parents’ experience facing cancer is what inspires my work at MSD – pursuing breakthrough science to not only prolong lives, but protect them, too. That’s why we’re urgently tackling obstacles that can help close the care gap – from working to increase screening rates and ensuring our trials are diverse and equitable, to breaking down barriers that stand in the way of treatments reaching those who need them most.
Dr. Marjorie Green
senior vice president and head of oncology, global clinical development, MSD Research Laboratories
World Cancer Day is a powerful opportunity to speak out, to call for action, to listen to cancer patients and their families, and to give them a voice.
Ana Fernández-Marcos
Director of Advocacy, Institutional Affairs & Strategic Alliances Spanish Association Against Cancer and Executive Board Member, Association of European Cancer Leagues (ECL)
The American Cancer Society’s vision is a world without the pain and suffering of cancer. World Cancer Day helps bring home the message to all Americans and everyone around the world that where you live shouldn’t determine if you live.
Ambassador Sally G. Cowal
Senior Vice President, Global Cancer Control, American Cancer Society, Inc.
On World Cancer Day and beyond, it’s essential that we focus on cancer and help close the care gap. At Novartis, we are committed to bringing more medicines to more people, no matter where they are, and will continue to support the efforts of UICC and everyone working to ensure that where someone lives does not determine the outcome of a cancer diagnosis.
Marie-France Tschudin
President, Innovative Medicines International & Chief Commercial Officer, Novartis
World Cancer Day reminds us of the global emergency that is cancer and how each of us play our part in controlling the disease.
Ebele Mbanugo, Ed.D
Founder/Executive Director, Run For a Cure Africa
All the hundreds of activities organised on World Cancer Day happen in almost every corner of the globe. World Cancer Day has become the most amplified and impactful global platform for all cancer patients and advocates - a platform where we can all make noise, lots of noise, reminding all that we can win the war on cancer.
HRH Princess Dina Mired of Jordan
World Cancer Day is an excellent platform that has given us the opportunity to raise greater awareness about the cause and further galvanise the community to come together in the collective fight against cancer.
Albert Ching
CEO, Singapore Cancer Society
As a proud supporter of World Cancer Day, we believe that together with partners from across sectors and geographies, we can make a difference and close the care gap. It is only when we listen to local communities and understand their challenges that we can develop tailored solutions to tackle access barriers one step at a time.
Michael Oberreiter
Head of Global Access, Roche
World Cancer Day has provided us with the opportunity to engage with many actors globally, reinforcing the power of a united cancer community working towards a world without cancer.
Dr. Maira Caleffi
Volunteer President, FEMAMA
My connection to fighting cancer is personal as it is for so many others. MSD is at the forefront of cancer research, with inventions that are helping to transform the prevention and treatment of disease. Beyond research, we are committed to global and local partnerships to help close the care gap. I believe collaboration is essential to create a world where cancer screening, treatment and care are accessible and equitable for all.
Sophie Opdyke
SVP Global Oncology Marketing, MSD
We believe that through the power of collaboration it’s possible to address and eventually overcome barriers to access in healthcare around the globe . We are proud to join with the UICC in support of World Cancer Day and are grateful for the dedication of all our global partners as together we work toward offering each person with cancer a better, healthier life.
Estelle D. Vester-Blokland
MD, Senior Vice President, Global Medical Affairs, BMS
As a sponsor for World Cancer Day, we believe that your health matters, no matter your age. As a part of our When Cancer Grows Old™ initiative, Sanofi is collaborating with the global cancer community, including advocates and healthcare providers around the world, to give people with cancer the best possible chance to grow older.
Vanina Laurent-Ledru
Vice President of Global Public Affairs, Sanofi Specialty Care, SANOFI
While science continues to explore the potential for cures, every cancer journey is full of challenges from many angles and World Cancer Day is an opportunity to amplify the important work being done globally to help close the care gap in cancer. We are committed to working with partners like UICC to confront health inequities in cancer and help patients and their families access critical supportive resources.
Jean-Charles Soria
Senior Vice President Global Development Oncology, Amgen
For Boehringer Ingelheim, cancer care is personal, today and for generations. Our aspiration is to transform the lives of people living with cancer, which we firmly believe requires collaboration. This is why we proudly support the UICC’s World Cancer Day initiative catalysing action to reduce the global impact of cancer.
Francesco Di Marco, Ph.D.
Corporate Senior Vice President, Global Therapy Area Head, Oncology, Boehringer Ingelheim
Image
Thanks to our Partners
Visionary
Champion
World Cancer Day is an initiative of the Union for International Cancer Control (UICC)
UICC is a registered non-profit association and donations can be deducted from taxes in select countries.Tax-exempt numbers:Switzerland: CHE-107.751.349USA: 23-7208844 | Status: 501(c)(3)
Main navigation
About
Our story
Why cancer?
Campaign theme
Press & media
FAQs
Understanding Cancer
What is cancer?
Close the care gap
Key issues
Spotlight: Cervical cancer elimination
Useful links & resources
Take action
Join Call to Action
Share Call to Action
World Cancer Day 5k Challenge
Who should get involved
Share your story
4 Feb Live
Materials
Create your own custom poster
Posters
Social media
Social infographics
Toolkits
How to guides
Map of Activities
Add your activity
Our supporters
Stay updated
youtube
ticktok
ENFRESITARHIZH-HANSIDRU
Contact
Footer menu
T&C
Privacy
Cookie preferences
© 2024 UICC | World Cancer Day, All rights reserved
Contact us | UICC
Contact us | UICC
Skip to main content
Main navigation
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
Read more
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Get involved
Main navigation
Who we are
About UICC
What is cancer control?
Annual reports
Our team
Recognition and awards
UICC strategy
UICC's values
Environmental sustainability
UICC and TNM
History of UICC
Contact us
Governance
General Assembly
General Assembly 2022
Previous general assemblies
Board of Directors
2022-2024 Board of Directors and President-elect profiles
President
President-elect
CEO
Job opportunities
Press centre
What we do
Member benefits
Learning and development
Online learning
Master courses
Self-guided courses
Micro-courses
Grants
Implementation research for cancer prevention in Europe
Solidarity Fund to aid Ukrainian cancer patients
Grants for the early detection of breast cancer
SPARC MBC Challenge
Fellowships
Technical Fellowships
Virtual Fellowships
Bourses pour l’Afrique Francophone (BAF)
Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants
Fellowship Outcomes and Impact
Association of UICC Fellows
Past successes
Organisational leadership
Cancer Advocates programme
Patient Group Mentoring programme
Regional focus
Regional Dialogues
Africa
North America
Latin America
Eastern Mediterranean
Europe
Asia-Pacific
Members' corner
Sharing knowledge
Virtual Dialogues
Ageing and Cancer series
Alcohol and Cancer series
Breast Cancer series
Cancer Beyond COVID-19 series
Cervical Cancer Elimination series
Tobacco Control and Cancer series
UHC and cancer control series
Fellowships
TNM
TNM project structure
Publications and resources
E-learning
TNM Help Desk
Essential TNM
Global Initiative for Cancer Registries (GICR)
UICC journals
UICC newsletter
Events
World Cancer Day
The campaign
Why World Cancer Day matters
World Cancer Congress
World Cancer Congress 2024
World Cancer Congress 2022
Past Congresses
World Cancer Leaders' Summit
World Cancer Leaders' Summit 2023
Programme, speakers and awards
Host a World Cancer Leaders' Summit
Past Summits
Regional Dialogues
Driving global impact
Targeted commitments
Cancer Resolution
World Cancer Declaration
Global cancer commitments navigator
Global strategy for the elimination of cervical cancer
Global Breast Cancer Initiative
Advocacy
UICC Advocacy Network
What is cancer control advocacy?
Advocacy impact
Cancer control planning
New initiatives
City Cancer Challenge (C/Can)
International Cancer Control Partnership (ICCP)
McCabe Centre for Law and Cancer
NCD Alliance
Access to Oncology Medicines (ATOM) Coalition
About ATOM Coalition
Focus areas
Coalition partners
News & resources
Young Leaders programme
Young Leaders 2023-2024
Young Leaders Alumni
Thematic areas
Antimicrobial resistance (AMR)
World AMR Awareness Week (WAAW)
The role of UICC and its members on AMR
Resources for antimicrobial resistance
Breast cancer
Breast Cancer Awareness Month
UICC’s actions on breast cancer
Resources for breast cancer control
Breast Cancer programme
Cancer and ageing
Cancer and air pollution
Cancer and alcohol
Cancer prevention
Cervical cancer elimination
UICC's actions on cervical cancer
Resources for cervical cancer
Essential cancer medicines
Investing in cancer control
Patient engagement
Tobacco control
Resources for tobacco control
World No Tobacco Day
Universal health coverage (UHC)
2023 High-Level Meeting on Universal Health Coverage
Women and cancer
Who we work with
Members
Membership categories and fees
Map of members
Apply for membership
Renew membership
Member testimonials
UICC Awards
Partners
Our partners
Become a partner
Partners news and blog articles
Partner testimonials
UN Partners
World Health Organization (WHO)
International Agency for Research on Cancer (IARC)
International Atomic Energy Agency (IAEA)
Resources
Access all resources
Case studies
Podcasts
TNM Help Desk
News and updates
Breadcrumb
Who we are | About UICC
Contact us
Contact us
Have a question? Interest in becoming a member? Want to contribute to our work as a partner? Get in touch with UICC.
PLEASE NOTE
UICC does not respond to any questions regarding treatment and is not in position to assist patients medically and/or financially. For such inquiries, please consult our list of member organisations in the relevant country and contact them directly.
Address
Union for International Cancer Control (UICC)
31-33 Avenue Giuseppe Motta
1202 Geneva
Switzerland
info@uicc.org
T: +41 22 809 1811
Donations
UICC is a registered non-profit association and donations can be deducted from taxes in select countries.
Tax-exempt numbers:
Switzerland: CHE-107.751.349
USA: 23-7208844 | Status: 501(c)(3)
Get directions
Last update
Friday 10 February 2023
Share this page
Sign up to our mailing list
Sign up to stay informed about the latest updates from UICC and its community
View past newsletters
Visit our other websites
worldcancerday.org
worldcancercongress.org
iccp-portal.org
Get in touch
info@uicc.org
+41 22 809 1811
Follow us on Social Media
© 2023 UICC. All Rights Reserved.
Footer
Privacy
Terms & Conditions
Copyright
Consent configuration